CynergisTek Inc (NYSEAMERICAN:CTEK) Short Interest Down 7.4% in January

CynergisTek Inc (NYSEAMERICAN:CTEK) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 17,400 shares, a decline of 7.4% from the January 15th total of 18,800 shares. Based on an average daily trading volume, of 27,200 shares, the short-interest ratio is presently 0.6 days. Currently, 0.2% of the shares of the company are sold short.

A number of research firms have recently weighed in on CTEK. TheStreet cut CynergisTek from a “c-” rating to a “d” rating in a report on Monday, November 11th. Zacks Investment Research raised CynergisTek from a “hold” rating to a “buy” rating and set a $4.00 price target on the stock in a report on Tuesday.

NYSEAMERICAN CTEK opened at $3.96 on Friday. CynergisTek has a 12 month low of $2.44 and a 12 month high of $5.00.

Several hedge funds and other institutional investors have recently bought and sold shares of CTEK. King Luther Capital Management Corp increased its stake in shares of CynergisTek by 10.1% during the fourth quarter. King Luther Capital Management Corp now owns 443,880 shares of the company’s stock valued at $1,465,000 after acquiring an additional 40,568 shares during the period. Connors Investor Services Inc. increased its stake in shares of CynergisTek by 23.3% during the third quarter. Connors Investor Services Inc. now owns 71,450 shares of the company’s stock valued at $220,000 after acquiring an additional 13,500 shares during the period. Essex Investment Management Co. LLC increased its stake in shares of CynergisTek by 3.7% during the fourth quarter. Essex Investment Management Co. LLC now owns 151,945 shares of the company’s stock valued at $501,000 after acquiring an additional 5,445 shares during the period. BlackRock Inc. increased its stake in shares of CynergisTek by 21.0% during the second quarter. BlackRock Inc. now owns 27,501 shares of the company’s stock valued at $133,000 after acquiring an additional 4,771 shares during the period. Finally, Morgan Stanley increased its stake in shares of CynergisTek by 208.0% during the second quarter. Morgan Stanley now owns 5,135 shares of the company’s stock valued at $25,000 after acquiring an additional 3,468 shares during the period.

About CynergisTek

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Featured Article: Balance Sheet

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.